Title:Starring Role of Biomarkers and Anticancer Agents as a Major
Driver in Precision Medicine of Cancer Therapy
Volume: 23
Issue: 2
关键词:
精准医学、癌症生物标志物、抗癌药物、基因组学、恶性肿瘤生长、治疗方式。
摘要: Precision medicine is the most modern contemporary medicine approach
today, based on great amount of data on people's health, individual characteristics, and
life circumstances, and employs the most effective ways to prevent and cure diseases.
Precision medicine in cancer is the most precise and viable treatment for every cancer
patient based on the disease's genetic profile. Precision medicine changes the standard
one size fits all medication model, which focuses on average responses to care.
Consolidating modern methodologies for streamlining and checking anticancer drugs
can have long-term effects on understanding the results. Precision medicine can help
explicit anticancer treatments using various drugs and even in discovery, thus becoming
the paradigm of future cancer medicine. Cancer biomarkers are significant in precision
medicine, and findings of different biomarkers make this field more promising and
challenging. Naturally, genetic instability and the collection of extra changes in malignant
growth cells are ways cancer cells adapt and survive in a hostile environment, for
example, one made by these treatment modalities. Precision medicine centers on
recognizing the best treatment for individual patients, dependent on their malignant
growth and genetic characterization. This new era of genomics progressively referred to
as precision medicine, has ignited a new episode in the relationship between genomics
and anticancer drug development.
